Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was incorporated in 2000 and is headquartered in Helsinki, Finland.
Stock data | 2024 | Change |
---|---|---|
Price | $4.01 | N/A |
Market Cap | $27.15M | N/A |
Shares Outstanding | 6.77M | N/A |
Employees | 37.00 | N/A |